ePrivacy and GPDR Cookie Consent by TermsFeed Generator

Detail of the clinical trial

Title of the trial A double-blind, randomized, stratified, multi-center trial evaluating conventional and high dose oseltamivir in the treatment of immunocompromised patients with influenza
EudraCT number 2006-002468-24
Protocol number NV20234 (3.podání)
Sponsor F.Hoffmann-La Roche Ltd.
Indications Vaccination
Diagnosis influenza in immunocompromised patients
Population in clinical trial Infants and Toddlers (28 days - 23 months)
Children (2-11 years)
Adolescents (12-17 years)
Adults (18-65 years)
Elderly ( > 65 years)
Year of receiving the request to Institute (SÚKL) 2011
Date of approval by Institute (SÚKL) 2.3.2011
Date of approval by EC 7.11.2007
Date of initiation CT in ČR 6.1.2012
Date of ending CT in ČR 8.4.2015
Sites Klinika dětské hematologie a onkologie UK 2. LF, Motol Praha
RA, B. Němcové 113, Terezín, 411 55
Kasmed s.r.o., Klokotská 10, Tábor, 390 01
RA, Štefánikova 477, Zlín, 760 01

‹‹ Back to list